Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 871.20
-25.50 (-2.84%)
At close: Mar 30, 2026
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 902.29 billion as of March 30, 2026. Its market cap has decreased by -1.18% in one year.
Market Cap
902.29B
Enterprise Value
955.85B
Revenue
260.89B
Ranking
n/a
PE Ratio
18.27
Stock Price
871.20
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 902.29B, an increase of 10,909.19%. That is a compound annual growth rate of 21.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 902.29B | -1.93% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.59T |
| Cipla | 1.00T |
| Mankind Pharma | 841.67B |
| Aurobindo Pharma | 763.29B |
| Alkem Laboratories | 639.02B |
| Glenmark Pharmaceuticals | 612.52B |
| Laurus Labs | 544.61B |
| Ipca Laboratories | 402.37B |